`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Commissioner for Patents
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22314-1450
`www.uspto.gov
`
`Frank Cottingham
`Regeneron Pharmaceuticals Inc.
`777 Old Saw Mill River Rd.
`Tarrytown, NY 10591-6707
`
`Dear Mr. Cottingham:
`
`In Re: Patent Term Extension
`Application for
`U.S. Patent No. 7,070,959
`
`M
`AY 25 2016
`
`A certificate under 35 U.S.C. § 156 is enclosed extending the term of U.S. Patent
`No.7,070,959 for a period of 1,119 days. While a courtesy copyofthis letter is being forwarded
`to the Food and Drug Administration (FDA), you should directly correspond with the FDA
`regarding any requited changes to patent expiration dates as necessary.
`
`Inquiries regarding this communication shouldbe directed to the undersigned by telephone at
`(571) 272-7755, or by e-mail at mary.till@uspto.gov.
`
`i Mary C. Tél
`Senior Legal Advisor
`Office of Patent Legal Administration
`Office of the Deputy Commissioner
`for Patent Examination Policy
`
`cc:
`
`Food and Drug Administration
`CDER,Office of Regulatory Policy
`10903 New Hampshire Avenue,
`Bldg. 51 Room 6250
`Silver Spring MD 20993-0002
`
`Attention: Beverly Friedman
`
`RE: EYLEA® (aflibercept)
`Docket No.: FDA-2012-E-0489
`
`Mylan Exhibit 1128
`Mylan v. Regeneron, IPR2021-00881
`Page 1
`
`Mylan Exhibit 1128
`Mylan v. Regeneron, IPR2021-00881
`Page 1
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`(12)
`
`CERTIFICATE EXTENDING PATENT TERM
`UNDER35 U.S.C. § 156
`
`(68) PATENT NO.
`(45)
`ISSUED
`
`(75) INVENTOR
`(73) PATENT OWNER
`(95) PRODUCT
`
`:
`:
`
`:
`:
`:
`
`7,070,959
`‘July 4, 2006
`
`Nicholas J. Papadopoulos.etal.
`Regeneron Pharmaceuticals Inc.
`EYLEA® (aflibercept)
`
`Thisis to certify that an application under 35 U.S.C. § 156 has been filed in the United
`States Patent and Trademark Office, requesting extension of the term of U.S. Patent No.
`7,070,959 based uponthe regulatory review ofthe product EYLEA®(aflibercept) by the
`Food and Drug Administration. Since it appears that the requirements of thelaw have
`been met, this certificate extends the term of the patentfor the period of
`
`(94)
`
`1,119 days
`
`from May 23, 2020,the original expiration date of the patent, ‘subject to the payment of
`maintenancefees as provided by law, with all nights pertaining thereto as provided by 35
`U.S.C. § 156.
`
`I have caused the seal of the United States Patent and
`- Trademark Office to be affixed this 19th day of May 2016.
`
`
`
`Michelle K. Lee
`
`Under Secretary of Commercefor Intellectual Property and
`Director of the United States Patent and Trademark Office
`
`Mylan Exhibit 1128
`Mylan v. Regeneron, IPR2021-00881
`. Page 2
`
`Mylan Exhibit 1128
`Mylan v. Regeneron, IPR2021-00881
`Page 2
`
`